Teladoc Health (TDOC) and PayPal (PYPL) have both experienced significant declines, down over 80% in the past five years, following initial pandemic-driven surges. Teladoc, a telemedicine leader, faces challenges from increased competition and a shift back to in-person care, leading to stagnation in its total visits and ongoing unprofitability. Despite attempts to expand internationally and enhance its virtual therapy offerings, the outlook remains cautious for Teladoc.
Conversely, PayPal, while also seeing a slowdown in growth post-pandemic, retains a strong brand reputation and competitive edge in the fintech space. With 439 million active accounts and a total payment volume of $1.79 trillion, PayPal is well-positioned to capitalize on the growing digital payment market. Additionally, its foray into digital advertising could provide a lucrative revenue stream in the future.
Investors may find potential value in PayPal as a long-term hold, while Teladoc’s uncertain recovery prospects suggest a more cautious approach is warranted for that stock.
Source: fool.com